Vid Desai FDA’s Chief Information Officer | Official Website
Vid Desai FDA’s Chief Information Officer | Official Website
This is a 47.1% decrease from the number of companies inspected in the previous quarter, when 17 companies received 17 inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected worked in the Biologics sector.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
B & B Corner Corporation | Food and Cosmetics | 02/22/2024 | Voluntary Action Indicated (VAI) |
Baker Boat Corporation | Food and Cosmetics | 02/15/2024 | No Action Indicated (NAI) |
Beyond International, Inc. | Devices | 02/28/2024 | Voluntary Action Indicated (VAI) |
Family Fertility Center | Biologics | 01/30/2024 | No Action Indicated (NAI) |
La Vaquita, Inc. | Food and Cosmetics | 01/26/2024 | No Action Indicated (NAI) |
Mv & Sons Texas LP | Food and Cosmetics | 01/10/2024 | No Action Indicated (NAI) |
Rash Catering Services, LLC | Food and Cosmetics | 02/22/2024 | Official Action Indicated (OAI) |
San Martin Distributing, Inc. | Food and Cosmetics | 01/04/2024 | Voluntary Action Indicated (VAI) |
Texas Donor Services, Inc. | Biologics | 02/01/2024 | No Action Indicated (NAI) |